200 related articles for article (PubMed ID: 16524383)
1. Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Ono K; Yamada M
J Neurochem; 2006 Apr; 97(1):105-15. PubMed ID: 16524383
[TBL] [Abstract][Full Text] [Related]
2. Anti-fibrillogenic and fibril-destabilizing activities of anti-Parkinsonian agents for alpha-synuclein fibrils in vitro.
Ono K; Hirohata M; Yamada M
J Neurosci Res; 2007 May; 85(7):1547-57. PubMed ID: 17387689
[TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for alpha-synuclein fibrils in vitro.
Hirohata M; Ono K; Morinaga A; Yamada M
Neuropharmacology; 2008 Mar; 54(3):620-7. PubMed ID: 18164319
[TBL] [Abstract][Full Text] [Related]
4. Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases.
Ono K; Yamada M
Neurobiol Dis; 2007 Feb; 25(2):446-54. PubMed ID: 17169566
[TBL] [Abstract][Full Text] [Related]
5. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
[TBL] [Abstract][Full Text] [Related]
6. Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases.
Ono K; Hirohata M; Yamada M
Exp Neurol; 2007 Jun; 205(2):414-24. PubMed ID: 17425956
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.
Ono K; Noguchi-Shinohara M; Yoshita M; Naiki H; Yamada M
Exp Neurol; 2007 Feb; 203(2):579-83. PubMed ID: 17011551
[TBL] [Abstract][Full Text] [Related]
8. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2005 Oct; 336(2):444-9. PubMed ID: 16153607
[TBL] [Abstract][Full Text] [Related]
9. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochem Biophys Res Commun; 2005 Apr; 330(1):111-6. PubMed ID: 15781239
[TBL] [Abstract][Full Text] [Related]
10. Anti-aggregation and fibril-destabilizing effects of sex hormones on alpha-synuclein fibrils in vitro.
Hirohata M; Ono K; Morinaga A; Ikeda T; Yamada M
Exp Neurol; 2009 Jun; 217(2):434-9. PubMed ID: 19289119
[TBL] [Abstract][Full Text] [Related]
11. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.
Ono K; Hirohata M; Yamada M
Biochem Biophys Res Commun; 2006 Mar; 341(4):1046-52. PubMed ID: 16460684
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation.
Hirohata M; Ono K; Morinaga A; Ikeda T; Yamada M
Neurosci Lett; 2011 Mar; 491(1):48-52. PubMed ID: 21215793
[TBL] [Abstract][Full Text] [Related]
13. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
Takahashi R; Ono K; Takamura Y; Mizuguchi M; Ikeda T; Nishijo H; Yamada M
J Neurochem; 2015 Sep; 134(5):943-55. PubMed ID: 26016728
[TBL] [Abstract][Full Text] [Related]
14. Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
Exp Neurol; 2004 Oct; 189(2):380-92. PubMed ID: 15380488
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disorders.
Ono K; Hirohata M; Yamada M
Curr Pharm Des; 2008; 14(30):3247-66. PubMed ID: 19075704
[TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
[TBL] [Abstract][Full Text] [Related]
17. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease.
Ono K; Yoshiike Y; Takashima A; Hasegawa K; Naiki H; Yamada M
J Neurochem; 2003 Oct; 87(1):172-81. PubMed ID: 12969264
[TBL] [Abstract][Full Text] [Related]
18. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Biochim Biophys Acta; 2004 Nov; 1690(3):193-202. PubMed ID: 15511626
[TBL] [Abstract][Full Text] [Related]
19. Anti-Parkinsonian agents have anti-amyloidogenic activity for Alzheimer's beta-amyloid fibrils in vitro.
Ono K; Hasegawa K; Naiki H; Yamada M
Neurochem Int; 2006 Mar; 48(4):275-85. PubMed ID: 16343694
[TBL] [Abstract][Full Text] [Related]
20. Effect of melatonin on α-synuclein self-assembly and cytotoxicity.
Ono K; Mochizuki H; Ikeda T; Nihira T; Takasaki J; Teplow DB; Yamada M
Neurobiol Aging; 2012 Sep; 33(9):2172-85. PubMed ID: 22118903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
